Economic expertise of alirocumab in standard lipid lowering therapy insusceptibility

Usage of PCSK9 inhibitors is a new approach of lipid lowering therapy allowing overcomes as well insusceptibility of standard statins' therapy as their intolerance. In last case PCSK9 inhibitors can substitute statins in the treatment program. Introduction to the Russian clinical practice the n...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: S. K. Zyryanov (Auteur), I. N. Dyakov (Auteur)
Formaat: Boek
Gepubliceerd in: Izdatelstvo OKI, 2018-05-01T00:00:00Z.
Onderwerpen:
Online toegang:Connect to this object online.
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Internet

Connect to this object online.

3rd Floor Main Library

Exemplaargegevens van 3rd Floor Main Library
Plaatsingsnummer: A1234.567
Kopie 1 Beschikbaar